MARSILI, ANGELA
 Distribuzione geografica
Continente #
NA - Nord America 405
EU - Europa 175
AS - Asia 89
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 680
Nazione #
US - Stati Uniti d'America 399
IT - Italia 70
DE - Germania 42
CN - Cina 37
SG - Singapore 33
NL - Olanda 32
IN - India 15
IE - Irlanda 10
CI - Costa d'Avorio 7
FI - Finlandia 7
UA - Ucraina 5
CA - Canada 4
VN - Vietnam 4
GB - Regno Unito 3
BE - Belgio 2
BR - Brasile 2
EU - Europa 2
BZ - Belize 1
ES - Italia 1
MX - Messico 1
PT - Portogallo 1
RS - Serbia 1
SE - Svezia 1
Totale 680
Città #
Chandler 128
Ashburn 34
Amsterdam 30
Singapore 23
Millbury 17
Pune 14
Beijing 13
Nanjing 13
Des Moines 10
Naples 10
Princeton 10
Milan 9
Boston 8
Lawrence 7
Dearborn 6
Jacksonville 6
Leawood 5
Santa Clara 5
Seattle 5
Dong Ket 4
Los Angeles 4
Napoli 4
Ottawa 4
Davis 3
Wilmington 3
Changchun 2
Dublin 2
Formia 2
Guangzhou 2
Kronberg 2
Phoenix 2
Portici 2
Sant'arpino 2
Torre Annunziata 2
Waanrode 2
Washington 2
Whitby 2
Acerra 1
Albuquerque 1
Atlanta 1
Belize City 1
Buffalo 1
Cagliari 1
Caserta 1
Ceppaloni 1
Esslingen am Neckar 1
Fairfield 1
Gustavo Adolfo Madero 1
Hebei 1
Hefei 1
High Point 1
Houston 1
Jiaxing 1
Las Vegas 1
Madrid 1
Nanchang 1
Nola 1
Norwalk 1
Nuremberg 1
Nürnberg 1
Orange 1
Rio De Janeiro 1
Rome 1
Saint Louis 1
San Jose 1
Tianjin 1
Torino 1
Woodbridge 1
Xian 1
Totale 431
Nome #
Epoetin alfa increases frataxin production in Friedreich's ataxia without affecting hematocrit. 64
Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study 60
Dimethyl Fumarate Mediates Nrf2-dependent Mitochondrial Biogenesis in Mice and Humans 58
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study 55
The involvement of oxidative stress in bovine herpesvirus type 4-mediated apoptosis 52
Peripheral markers of autophagy in polyglutamine diseases 42
Stability of erythropoietin repackaging in polypropylene syringes for clinical use 41
Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple Sclerosis 41
Steroid treatment in Ataxia-Telangiectasia induces alterations of functional magnetic resonance imaging during prono-supination task. 39
Mobitz type I and II atrioventricular blocks during fingolimod therapy 39
‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab 36
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis 32
Eculizumab improves fatigue in refractory generalized myasthenia gravis 32
Consistent improvement with eculizumab across muscle groups in myasthenia gravis 30
Increased endothelin-1 serum levels in patients with multiple sclerosis 29
Correction to: Peripheral markers of autophagy in polyglutamine diseases (Neurological Sciences, (2018), 39, 1, (149-152), 10.1007/s10072-017-3156-6) 24
Safety and feasibility of upper limb cardiopulmonary exercise test in Friedreich ataxia 23
The C-Terminal Cross-linked Telopeptide of Type I Collagen (CTX-I) as a Potential Cardiomyopathy Biomarker in Friedreich Ataxia Patients 15
Rationale and protocol of a double-blind, randomized, placebo-controlled trial to test the efficacy, safety, and tolerability of dimethyl fumarate in Friedreich Ataxia (DMF-FA-201) 9
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension 5
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial 4
Totale 730
Categoria #
all - tutte 2.842
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.842


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202058 15 8 1 2 2 2 8 3 2 6 8 1
2020/202149 8 2 5 3 8 2 4 3 3 3 3 5
2021/202295 3 0 3 1 0 2 3 4 11 12 10 46
2022/2023253 21 39 1 26 26 31 1 22 38 33 11 4
2023/2024149 1 15 13 7 9 32 2 18 4 8 29 11
2024/202529 29 0 0 0 0 0 0 0 0 0 0 0
Totale 730